Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Fatigue
ADR ID BADD_A01626
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.002      Fatigue
Description A disorder characterized by a state of generalized weakness with a pronounced inability to summon sufficient energy to accomplish daily activities. [CTCAE] The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. [MeSH]
MedDRA Code 10016256
MeSH ID D005221; D005221; D005221
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Enervation | Exhaustion | Exhaustion due to excessive exertion | Exhaustion due to exposure | Fatigability | Fatigability generalized | Fatigability lumbar | Fatigability of knees | Fatigue | Fatigue extreme | Fatiguability | Lassitude | Loss physical strength | Prostration | TATT | Tired all the time | Tired and heavy | Tired out | Tiredness | Washed-out | Weariness | Worn out | Fatigue aggravated | Depressive weariness | Fatigueability generalised | Chronic fatigue | Fatiguability generalised
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Epidermal growth factor receptorP00533T59328
Receptor tyrosine-protein kinase erbB-2P04626T14597
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00552Cyproheptadine--
BADD_D00553Cyproheptadine hydrochloride--
BADD_D00554Cyproterone--
BADD_D00555Cyproterone acetate--
BADD_D00556Cysteamine--
BADD_D00560Cytarabine--
BADD_D00561Cytarabine hydrochloride--
BADD_D00564Dabigatran etexilate--
BADD_D00566Dabrafenib0.012255%
BADD_D00567Dabrafenib mesylate--
BADD_D00568Dacarbazine--
BADD_D00569Daclatasvir dihydrochloride--
BADD_D00571Dactinomycin--
BADD_D00574Dalfampridine--
BADD_D00576Danazol0.002823%
BADD_D00577Dantrolene sodium--
BADD_D00578Dapagliflozin--
BADD_D00580Dapsone--
BADD_D00581Daptomycin--
BADD_D00582Daratumumab--
BADD_D00586Darunavir--
BADD_D00587Darunavir ethanolate--
BADD_D00588Dasabuvir--
BADD_D00589Dasatinib0.104167%
BADD_D00590Daunorubicin--
BADD_D00591Daunorubicin citrate--
BADD_D00593Decitabine--
BADD_D00594Deferasirox--
BADD_D00595Deferiprone0.020409%
BADD_D00599Degarelix--
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 42 Pages